Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
Ticker SymbolSTSS
Company nameSharps Technology Inc
IPO dateApr 14, 2022
CEOMr. Robert M. Hayes
Number of employees5
Security typeOrdinary Share
Fiscal year-endApr 14
Address105 Maxess Road
CityMELVILLE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code11747
Phone15162464000
Websitehttps://sharpstechnology.com/
Ticker SymbolSTSS
IPO dateApr 14, 2022
CEOMr. Robert M. Hayes
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data